From Name:
From Email:
To Name:
To Email:

Optional Message:

FDA approves first cell-based gene therapy for adult patients with relapsed or refractory MCL

from FDA

On July 24, the U.S. Food and Drug Administration approved Tecartus, a cell-based gene therapy for treatment of adult patients diagnosed with mantle cell lymphoma who have not responded to or who have relapsed following other kinds of treatment. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063